We compared the effector functions and cytotoxicity of these CAR-T cell variants against a group of tumor cell lines with a wide range of EpCAM expression as well as human primary epithelial cells (EpC) (Fig. 1c–f). This evidence concerns the gene EPCAM and neoplasm.